Customer service in various sectors has faced significant criticism lately, particularly in airlines and supermarkets across the U.S. However, the cannabis industry, led by companies like Glass House Brands, is emerging as a surprising exception.
As the cannabis market matures, now valued at approximately $50 billion, its potential expands with recent federal reclassification of cannabis as a Schedule 3 drug, allowing for medical prescriptions. This shift underscores that cannabis is not just about recreational use; it also plays a role in managing symptoms for patients, including those undergoing cancer treatment.
During a recent visit to a dispensary in Connecticut, the professionalism of the staff stood out, offering a contrast to the frustrations often found in traditional retail. Charles Gasparino, a columnist for the New York Post, explored Glass House Brands, which operates one of America’s largest cannabis cultivation facilities in California. Under the leadership of President Graham Farrar, a former tech executive, the company is recognized for both its innovative practices and commitment to customer service.
Farrar’s operation spans 165 acres with massive greenhouses designed to optimize cultivation. He emphasizes the importance of cannabis beyond smoking, highlighting alternatives such as gummies and ointments tailored for various needs. The farm proudly employs sustainable practices, including solar energy and local water supplies, which position it favorably against competitors reliant on traditional power sources.
Despite the industry’s challenges—Glass House’s stock has experienced significant declines—optimism remains high. There’s growing bipartisan support for cannabis legalization, which promises improved banking services and enhanced regulation to ensure safe access for consumers.
Why this story matters
- Demonstrates a shift in customer service standards within a rapidly growing industry.
Key takeaway
- The cannabis sector is evolving beyond recreational use to include significant medical and consumer service benefits.
Opposing viewpoint
- Concerns remain regarding health risks and financial viability given the volatile nature of cannabis stocks.
